Citations (174)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (28)
Jean-François Yale, Beatrice Osumili, Beth D. Mitchell, Barnaby Hunt, Gurjeev Sohi, Mark Jeddi, Donna Mojdami & William J. Valentine. (2022) Evaluation of the cost and medical resource use outcomes associated with nasal glucagon versus injectable glucagon for treatment of severe hypoglycemia in people with diabetes in Canada: a modeling analysis. Journal of Medical Economics 25:1, pages 238-248.
Read now
Read now
Johan Jendle, Åsa Ericsson, Bertil Ekman, Stefan Sjöberg, Jens Gundgaard, João da Rocha Fernandes, Ann-Charlotte Mårdby, Barnaby Hunt, Samuel J. P. Malkin & Maria Thunander. (2020) Real-world cost-effectiveness of insulin degludec in type 1 and type 2 diabetes mellitus from a Swedish 1-year and long-term perspective. Journal of Medical Economics 23:11, pages 1311-1320.
Read now
Read now
Michael Weiner, Jonathan Cummins, Annaswamy Raji, Susan Ofner, Kristy Iglay, Evgenia Teal, Xiaochun Li, Samuel S. Engel, Kristina Knapp, Swapnil Rajpathak, Jarod Baker, Arnaub K. Chatterjee & Larry Radican. (2020) A randomized study on the usefulness of an electronic outpatient hypoglycemia risk calculator for clinicians of patients with diabetes in a safety-net institution. Current Medical Research and Opinion 36:4, pages 583-593.
Read now
Read now
Xiaochun Li, Shengsheng Yu, Zuoyi Zhang, Larry Radican, Jonathan Cummins, Samuel S. Engel, Kristy Iglay, Jon Duke, Jarod Baker, Kimberly G. Brodovicz, Ramachandra G. Naik, Jeremy Leventhal, Arnaub K. Chatterjee, Swapnil Rajpathak & Michael Weiner. (2019) Predictive modeling of hypoglycemia for clinical decision support in evaluating outpatients with diabetes mellitus. Current Medical Research and Opinion 35:11, pages 1885-1891.
Read now
Read now
Richard F Pollock, Barrie Chubb, William J Valentine & Simon Heller. (2018) Evaluating the cost-effectiveness of insulin detemir versus neutral protamine Hagedorn insulin in patients with type 1 or type 2 diabetes in the UK using a short-term modeling approach. Diabetes, Metabolic Syndrome and Obesity 11, pages 217-226.
Read now
Read now
Rosemarie Lajara, Eda Cengiz & Robert J. Tanenberg. (2017) The role of the new basal insulin analogs in addressing unmet clinical needs in people with type 1 and type 2 diabetes. Current Medical Research and Opinion 33:6, pages 1045-1055.
Read now
Read now
James Weatherall, Lisa Bloudek & Sarah Buchs. (2017) Budget impact of treating commercially insured type 1 and type 2 diabetes patients in the United States with insulin degludec compared to insulin glargine. Current Medical Research and Opinion 33:2, pages 231-238.
Read now
Read now
Ulrik Pedersen-Bjergaard, Peter Lommer Kristensen, Kirsten Nørgaard, Hans Perrild, Tonny Jensen, Birger Thorsteinsson, Annie Nikolajsen & Lise Tarnow. (2016) Short-term cost-effectiveness of insulin detemir and insulin aspart in people with type 1 diabetes who are prone to recurrent severe hypoglycemia. Current Medical Research and Opinion 32:10, pages 1719-1725.
Read now
Read now
Volker Foos, Nebibe Varol, Bradley H. Curtis, Kristina S. Boye, David Grant, James L. Palmer & Phil McEwan. (2015) Economic impact of severe and non-severe hypoglycemia in patients with Type 1 and Type 2 diabetes in the United States. Journal of Medical Economics 18:6, pages 420-432.
Read now
Read now
M. Evans, M. Wolden, J. Gundgaard, B. Chubb & T. Christensen. (2015) Cost-effectiveness of insulin degludec compared with insulin glargine in a basal-bolus regimen in patients with type 1 diabetes mellitus in the UK. Journal of Medical Economics 18:1, pages 56-68.
Read now
Read now
Lotta Walz, Billie Pettersson, Ulf Rosenqvist, Anna Deleskog, Gunilla Journath & Per Wändell. (2014) Impact of symptomatic hypoglycemia on medication adherence, patient satisfaction with treatment, and glycemic control in patients with type 2 diabetes. Patient Preference and Adherence 8, pages 593-601.
Read now
Read now
B. Peene, D. D’Hooge, T. Vandebrouck & C. Mathieu. (2014) Patient-reported frequency, awareness and patient-physician communication of hypoglycaemia in Belgium. Acta Clinica Belgica 69:6, pages 439-445.
Read now
Read now
Gregory Fulcher, Joelle Singer, Rutila Castañeda, Fadlo Fraige Filho, Laura Maffei, Jacques Snyman & Meryl Brod. (2014) The psychosocial and financial impact of non-severe hypoglycemic events on people with diabetes: two international surveys. Journal of Medical Economics 17:10, pages 751-761.
Read now
Read now
Stewart B Harris, Kamlesh Khunti, Mona Landin-Olsson, Claus B Galbo-Jørgensen, Mette Bøgelund, Barrie Chubb, Jens Gundgaard & Marc Evans. (2013) Descriptions of health states associated with increasing severity and frequency of hypoglycemia: a patient-level perspective. Patient Preference and Adherence 7, pages 925-936.
Read now
Read now
Meryl Brod, Azhar Rana & Anthony H. Barnett. (2012) Impact of self-treated hypoglycaemia in type 2 diabetes: a multinational survey in patients and physicians. Current Medical Research and Opinion 28:12, pages 1947-1958.
Read now
Read now
Meryl Brod, Torsten Christensen & Donald M. Bushnell. (2012) The impact of non-severe hypoglycemic events on daytime function and diabetes management among adults with type 1 and type 2 diabetes. Journal of Medical Economics 15:5, pages 869-877.
Read now
Read now
Johan Jendle, Sherry A Martin & Zvonko Milicevic. (2012) Insulin and GLP-1 analog combinations in type 2 diabetes mellitus: a critical review. Expert Opinion on Investigational Drugs 21:10, pages 1463-1474.
Read now
Read now
Shuqian Liu, Yingnan Zhao, James M Hempe, Vivian Fonseca & Lizheng Shi. (2012) Economic burden of hypoglycemia in patients with Type 2 diabetes. Expert Review of Pharmacoeconomics & Outcomes Research 12:1, pages 47-51.
Read now
Read now
Meryl Brod, Torsten Christensen & Donald M. Bushnell. (2012) Impact of nocturnal hypoglycemic events on diabetes management, sleep quality, and next-day function: results from a four-country survey. Journal of Medical Economics 15:1, pages 77-86.
Read now
Read now
Carrie Fidler, Torsten Elmelund Christensen & Samantha Gillard. (2011) Hypoglycemia: An overview of fear of hypoglycemia, quality-of-life, and impact on costs. Journal of Medical Economics 14:5, pages 646-655.
Read now
Read now
M Brito-Sanfiel, J Diago-Cabezudo & A Calderon. (2010) Economic impact of hypoglycemia on healthcare in Spain. Expert Review of Pharmacoeconomics & Outcomes Research 10:6, pages 649-660.
Read now
Read now
Mette Hammer, Morten Lammert, Susana Monereo Mejías, Werner Kern & Brian M. Frier. (2009) Costs of managing severe hypoglycaemia in three European countries. Journal of Medical Economics 12:4, pages 281-290.
Read now
Read now
RN Løding, JE Wold & Å Skavhaug. (2008) Experiences with a group intervention for adolescents with type 1 diabetes and their parents. European Diabetes Nursing 5:1, pages 9-14.
Read now
Read now
Miguel Debono & Elaine Cachia. (2007) The impact of diabetes on psychological well being and quality of life. The role of patient education. Psychology, Health & Medicine 12:5, pages 545-555.
Read now
Read now
P Banck-Petersen, T Larsen, U Pedersen-Bjergaard, L Bie-Olsen, T Høi-Hansen & B Thorsteinsson. (2007) Concerns about hypoglycaemia and late complications in patients with insulin-treated diabetes. European Diabetes Nursing 4:3, pages 113-118.
Read now
Read now
Phil McEwan, Chris D. Poole, Tony Tetlow, Paul Holmes & Craig J. Currie. (2007) Evaluation of the cost-effectiveness of insulin glargine versus NPH insulin for the treatment of type 1 diabetes in the UK. Current Medical Research and Opinion 23:sup1, pages S7-S19.
Read now
Read now
Craig J. Currie, Christopher Ll. Morgan, Chris D. Poole, Peter Sharplin, Morten Lammert & Phil McEwan. (2006) Multivariate models of health-related utility and the fear of hypoglycaemia in people with diabetes. Current Medical Research and Opinion 22:8, pages 1523-1534.
Read now
Read now
Phil McEwan, John R. Peters, Klas Bergenheim & Craig J. Currie. (2006) Evaluation of the costs and outcomes from changes in risk factors in type 2 diabetes using the Cardiff stochastic simulation cost-utility model (DiabForecaster). Current Medical Research and Opinion 22:1, pages 121-129.
Read now
Read now
Articles from other publishers (146)
Sara Charleer, Christophe De Block, Nancy BolsensLiesbeth Van HuffelFrank NobelsChantal MathieuPieter Gillard. (2023) Sustained Impact of Intermittently Scanned Continuous Glucose Monitoring on Treatment Satisfaction and Severe Hypoglycemia in Adults with Type 1 Diabetes (FUTURE): An Analysis in People with Normal and Impaired Awareness of Hypoglycemia. Diabetes Technology & Therapeutics.
Crossref
Crossref
Rossano Wells & Anria Knowles. (2023) The psychological and health benefits of using a continuous glucose monitor for a person with type 1 diabetes: A South African higher education context. F1000Research 12, pages 373.
Crossref
Crossref
Li Feng Xie, Amélie Roy-Fleming, Sarah Haag, Deborah Da Costa & Anne-Sophie Brazeau. (2023)
Development of the
Support
self-guided, web application for adults living with type 1 diabetes in Canada by a multi-disciplinary team using a people-oriented approach based on the Behaviour Change Wheel
. DIGITAL HEALTH 9, pages 205520762311527.
Crossref
Crossref
Michael Weiner, Philip Adeoye, Margaret J. Boeh, Kunal Bodke, Jessica Broughton, Anietra R. Butler, Mackenzie L. Dafferner, Lindsay A. Dirlam, Denisha Ferguson, Amanda L. Keegan, NiCole R. Keith, Joy L. Lee, Corrina B. McCorkle, Daniel G. Pino, Mu Shan, Preethi Srinivas, Qing Tang, Evgenia Teal, Wanzhu Tu, April Savoy, Christopher M. Callahan & Daniel O. Clark. (2022) Continuous Glucose Monitoring and Other Wearable Devices to Assess Hypoglycemia among Older Adult Outpatients with Diabetes Mellitus. Applied Clinical Informatics 14:01, pages 037-044.
Crossref
Crossref
Ravi Kant, Mc Anto Antony, David Geurkink, Nathan Gilreath, Lakshya Chandra, Elizabeth Zipprer, Kashif M. Munir, Rashmi Chandra, Veronica G. Parker & Vipin Verma. (2022) Real-time continuous glucose monitoring improves glycemic control and reduces hypoglycemia: Real-world data. Primary Care Diabetes 16:6, pages 786-790.
Crossref
Crossref
Anthony J. Pease, Sophia Zoungas, Emily Callander, Timothy W. Jones, Stephanie R. Johnson, D. Jane Holmes-Walker, David E. Bloom, Elizabeth A. Davis & Ella Zomer. (2022) Nationally Subsidized Continuous Glucose Monitoring: A Cost-effectiveness Analysis. Diabetes Care 45:11, pages 2611-2619.
Crossref
Crossref
Anthony Pease, Emily Callander, Ella Zomer, Mary B. Abraham, Elizabeth A. Davis, Timothy W. Jones, Danny Liew & Sophia Zoungas. (2022) The Cost of Control: Cost-effectiveness Analysis of Hybrid Closed-Loop Therapy in Youth. Diabetes Care 45:9, pages 1971-1980.
Crossref
Crossref
Athanasios Chantzaras & John Yfantopoulos. (2022) Evaluating the Incidence and Risk Factors Associated With Mild and Severe Hypoglycemia in Insulin-Treated Type 2 Diabetes. Value in Health Regional Issues 30, pages 9-17.
Crossref
Crossref
Uffe Søholm, Melanie Broadley, Natalie Zaremba, Patrick Divilly, Giesje Nefs, Zeinab Mahmoudi, Bastiaan de Galan, Ulrik Pedersen-Bjergaard, Alan Brennan, Daniel John Pollard, Rory J McCrimmon, Stephanie A. Amiel, Christel Hendrieckx, Jane Speight, Pratik Choudhary & Frans Pouwer. (2022) Investigating the day-to-day impact of hypoglycaemia in adults with type 1 or type 2 diabetes: design and validation protocol of the Hypo-METRICS application. BMJ Open 12:2, pages e051651.
Crossref
Crossref
Nicolas Chevalier, Alfred Penfornis, Jean-Pierre Riveline, Florence Chartier, Beth Mitchell, Beatrice Osumili, Erik Spaepen, Frank Snoek, Mark Peyrot & Imane Benabbad. (2022) Conversations and reactions around severe hypoglycemia (CRASH) global survey of people with type 1 diabetes or insulin-treated type 2 diabetes and caregivers: Findings from the French cohort. Annales d'Endocrinologie 83:1, pages 16-26.
Crossref
Crossref
Steven R. Kraaijeveld. (2020) Continuous Glucose Monitoring as a Matter of Justice. HEC Forum 33:4, pages 345-370.
Crossref
Crossref
Vanessa Botan, Graham R. Law, Despina Laparidou, Elise Rowan, Murray D. Smith, Colin Ridyard, Amanda Brewster, Robert Spaight, Keith Spurr, Pauline Mountain, Sally Dunmore, June James, Leon Roberts, Kamlesh Khunti & Aloysius N. Siriwardena. (2021) The effects of a leaflet‐based intervention, ‘Hypos can strike twice’, on recurrent hypoglycaemic attendances by ambulance services: A non‐randomised stepped wedge study. Diabetic Medicine 38:10.
Crossref
Crossref
F. Javier Ampudia-Blasco, Esther Artime, Silvia Díaz, Miriam Rubio, Jesús Reviriego, Beth Mitchell, Beatrice Osumili, Mark Peyrot, Robin Pokrzywinski, Erik Spaepen & Frank Snoek. (2021) Conversations and Reactions Around Severe Hypoglycaemia (CRASH): Spanish results of a global survey of people with type 1 diabetes or insulin-treated type 2 diabetes and caregivers. Endocrinología, Diabetes y Nutrición 68:8, pages 557-566.
Crossref
Crossref
F. Javier Ampudia-Blasco, Esther Artime, Silvia Díaz, Miriam Rubio, Jesús Reviriego, Beth Mitchell, Beatrice Osumili, Mark Peyrot, Robin Pokrzywinski, Erik Spaepen & Frank Snoek. (2021) Conversations and Reactions Around Severe Hypoglycaemia (CRASH): Spanish results of a global survey of people with type 1 diabetes or insulin-treated type 2 diabetes and caregivers. Endocrinología, Diabetes y Nutrición (English ed.) 68:8, pages 557-566.
Crossref
Crossref
Xuanqian Xie, Jennifer Guo, Karen E Bremner, Myra Wang, Baiju R Shah & Andrei Volodin. (2021) Review and estimation of disutility for joint health states of severe and nonsevere hypoglycemic events in diabetes. Journal of Comparative Effectiveness Research 10:13, pages 961-974.
Crossref
Crossref
Martine J Wellens, Charlotte E Vollenbrock, Pim Dekker, Lianne S M Boesten, Petronella H Geelhoed-Duijvestijn, Martine M C de Vries-Velraeds, Giesje Nefs, Bruce H R Wolffenbuttel, Henk-Jan Aanstoot & Peter R van Dijk. (2021) Residual C-peptide secretion and hypoglycemia awareness in people with type 1 diabetes. BMJ Open Diabetes Research & Care 9:1, pages e002288.
Crossref
Crossref
Mohanraj Thirumalai, Ayse G Zengul & Eric Evans. (2021) Challenges and Lessons Learned From a Telehealth Community Paramedicine Program for the Prevention of Hypoglycemia: Pre-Post Pilot Feasibility Study. JMIR Diabetes 6:3, pages e26941.
Crossref
Crossref
Kajsa Sjöholm, Peter Jacobson, Magdalena Taube, Per‐Arne Svensson, Johanna C. Andersson Assarsson, Lena M. S. Carlsson & Markku Peltonen. (2021)
Long‐term incidence of hypoglycaemia‐related events after bariatric surgery or usual care in the
Swedish
Obese Subjects study: A register‐based analysis
. Diabetes, Obesity and Metabolism 23:8, pages 1917-1925.
Crossref
Crossref
Roy W. Beck & Richard M. Bergenstal. (2021) Beyond A1C—Standardization of Continuous Glucose Monitoring Reporting: Why It Is Needed and How It Continues to Evolve. Diabetes Spectrum 34:2, pages 102-108.
Crossref
Crossref
Chantal Mathieu. (2021) Minimising hypoglycaemia in the real world: the challenge of
insulin. Diabetologia 64:5, pages 978-984.
Crossref
Crossref
Yanhao Wang, Zihuan Zeng, Jie Ding, Ruizhu Yuan, Ruiding Wang, You Zhang, Liyao Bai, Huan Yu & Jiao Tang. (2021) Fear of hypoglycaemia among patients with type 2 diabetes mellitus: a cross-sectional study. Scientific Reports 11:1.
Crossref
Crossref
Pedro J. Pinés Corrales, Cristina Arias Lozano, Cortes Jiménez Martínez, Luz M. López Jiménez, Alejandro E. Sirvent Segovia, Lourdes García Blasco & Francisco Botella Romero. (2021) Prevalencia de hipoglucemia grave en una cohorte de pacientes con diabetes tipo 1. Endocrinología, Diabetes y Nutrición 68:1, pages 47-52.
Crossref
Crossref
Pedro J. Pinés Corrales, Cristina Arias Lozano, Cortes Jiménez Martínez, Luz M. López Jiménez, Alejandro E. Sirvent Segovia, Lourdes García Blasco & Francisco Botella Romero. (2021) Prevalence of severe hypoglycemia in a cohort of patients with type 1 diabetes. Endocrinología, Diabetes y Nutrición (English ed.) 68:1, pages 47-52.
Crossref
Crossref
Kshitiz Ghandi, Beatrice Pieri, Anne Dornhorst & Sufyan Hussain. (2020) A Comparison of Validated Methods Used to Assess Impaired Awareness of Hypoglycaemia in Type 1 Diabetes: An Observational Study. Diabetes Therapy 12:1, pages 441-451.
Crossref
Crossref
Anita Andreano, Marco Bosio & Antonio Giampiero Russo. (2020) Emergency attendance for acute hyper- and hypoglycaemia in the adult diabetic population of the metropolitan area of Milan: quantifying the phenomenon and studying its predictors. BMC Endocrine Disorders 20:1.
Crossref
Crossref
Itivrita Goyal, Alamgir Sattar, Megan Johnson & Paresh Dandona. (2020) Adjunct therapies in treatment of type 1 diabetes. Journal of Diabetes 12:10, pages 742-753.
Crossref
Crossref
Judith B. Brown, Yashoda Valliere, Cecelia McLachlan, Sonja M. Reichert, Susan Webster-Bogaert, Alexandria Ratzki-Leewing, Bridget L. Ryan & Stewart B. Harris. (2020) Beyond the Sick Role: The Many Roles of Adults With Type 1 and Type 2 Diabetes in the Management of Hypoglycemia—The InHypo-DM Study, Canada. Canadian Journal of Diabetes 44:7, pages 657-662.
Crossref
Crossref
Karla F. S. Melo, Luciana R. Bahia, Bruna Pasinato, Gustavo J. M. Porfirio, Ana Luiza Martimbianco, Rachel Riera, Luis E. P. Calliari, Walter J. Minicucci, Luiz A. A. Turatti, Hermelinda C. Pedrosa & Beatriz D. Schaan. (2019) Short-acting insulin analogues versus regular human insulin on postprandial glucose and hypoglycemia in type 1 diabetes mellitus: a systematic review and meta-analysis. Diabetology & Metabolic Syndrome 11:1.
Crossref
Crossref
Karina Mayoral, Luis Rajmil, Marta Murillo, Olatz Garin, Angels Pont, Jordi Alonso, Joan Bel, Jacobo Perez, Raquel Corripio, Gemma Carreras, Javier Herrero, Jose-Maria Mengibar, Dolors Rodriguez-Arjona, Ulrike Ravens-Sieberer, Hein Raat, Vicky Serra-Sutton & Montse Ferrer. (2019) Measurement Properties of the Online EuroQol-5D-Youth Instrument in Children and Adolescents With Type 1 Diabetes Mellitus: Questionnaire Study. Journal of Medical Internet Research 21:11, pages e14947.
Crossref
Crossref
Thongchai Pratipanawatr, Bancha Satirapoj, Boonsong Ongphiphadhanakul, Sompongse Suwanwalaikorn & Wannee Nitiyanant. (2019) Impact of Hypoglycemia on Health-Related Quality of Life among Type 2 Diabetes: A Cross-Sectional Study in Thailand. Journal of Diabetes Research 2019, pages 1-8.
Crossref
Crossref
Malin Nilsson, Nicole Jensen, Michael Gejl, Marianne L. Bergmann, Heidi Storgaard, Mette Zander, Kamilla Miskowiak & Jørgen Rungby. (2019) Experimental non-severe hypoglycaemia substantially impairs cognitive function in type 2 diabetes: a randomised crossover trial. Diabetologia 62:10, pages 1948-1958.
Crossref
Crossref
Ana María Gómez, Luis G. Chica, Álvaro F. Burbano, Esdras M. Vásquez, Jorge A. Escobar, Paola M. Arias & Dora I. Molina. (2019) Survey on hypoglycemia among insulin-treated patients with diabetes: The Colombian International Operations Hypoglycemia Assessment Tool population. Biomédica 39:3, pages 576-586.
Crossref
Crossref
C. Hendrieckx, N. Ivory, H. Singh, B. M. Frier & J. Speight. (2019) Impact of severe hypoglycaemia on psychological outcomes in adults with Type 2 diabetes: a systematic review. Diabetic Medicine 36:9, pages 1082-1091.
Crossref
Crossref
Judith Belle Brown, Sonja M. Reichert, Yashoda Valliere, Susan Webster-Bogaert, Alexandria Ratzki-Leewing, Bridget L. Ryan & Stewart B. Harris. (2019) Living With Hypoglycemia: An Exploration of Patients’ Emotions: Qualitative Findings From the InHypo-DM Study, Canada. Diabetes Spectrum 32:3, pages 270-276.
Crossref
Crossref
Angharad Ames, Carlos A Lago-Hernandez & Eduardo Grunvald. (2019) Hypoglycemia After Gastric Bypass Successfully Treated With Calcium Channel Blockers: Two Case Reports. Journal of the Endocrine Society 3:7, pages 1417-1422.
Crossref
Crossref
Ulrik Pedersen‐Bjergaard, Saud Alsifri, Ronnie Aronson, Maja Cigrovski Berković, Gagik Galstyan, Helge Gydesen, Jesper Barner Lekdorf, Bernhard Ludvik, Erik Moberg, Ambady Ramachandran & Kamlesh Khunti. (2019) Comparison of the HAT study, the largest global hypoglycaemia study to date, with similar large real‐world studies. Diabetes, Obesity and Metabolism 21:4, pages 844-853.
Crossref
Crossref
Simona Popoviciu, Anca Alionescu & Irma Sisic. (2019) Prevalence of Hypoglycemia, Treatment Satisfaction, Adherence and Their Associations with Glycemic Goals in Patients with Type 2 Diabetes Mellitus Treated with Sulfonylureas: Findings from the Real-Life Effectiveness and Care Patterns of Diabetes Management (RECAP-DM) in Romania. Romanian Journal of Diabetes Nutrition and Metabolic Diseases 26:1, pages 55-64.
Crossref
Crossref
Roy W. BeckRichard M. BergenstalTonya D. RiddlesworthCraig Kollman. (2019) The Association of Biochemical Hypoglycemia with the Subsequent Risk of a Severe Hypoglycemic Event: Analysis of the DCCT Data Set. Diabetes Technology & Therapeutics 21:1, pages 1-5.
Crossref
Crossref
James Weatherall, William H. Polonsky, Sally Lanar, Naomi Knoble, Jonas Håkan-Bloch, Elisabeth Constam, Athena Philis-Tsimikas & Alexia Marrel. (2018) When insulin degludec enhances quality of life in patients with type 2 diabetes: a qualitative investigation. Health and Quality of Life Outcomes 16:1.
Crossref
Crossref
Mohammed J. Alramadan, Dianna J. Magliano, Turky H. Almigbal, Mohammed Ali Batais, Afsana Afroz, Hesham J. Alramadhan, Waad Faozi Mahfoud, Adel Mehmas Alragas & Baki Billah. (2018) Glycaemic control for people with type 2 diabetes in Saudi Arabia – an urgent need for a review of management plan. BMC Endocrine Disorders 18:1.
Crossref
Crossref
Émilie Proulx, Audrey Auclair, Marie-Eve Piché, Jany Harvey, Myriam Pettigrew, Laurent Biertho, Simon Marceau & Paul Poirier. (2018) Safety of Blood Glucose Response Following Exercise Training After Bariatric Surgery. Obesity Surgery 28:12, pages 3976-3983.
Crossref
Crossref
Chantal Mathieu, Paresh Dandona, Pieter Gillard, Peter Senior, Christoph Hasslacher, Eiichi Araki, Marcus Lind, Stephen C. BainSerge Jabbour, Niki Arya, Lars Hansen, Fredrik Thorén, Anna Maria Langkilde, Cecilia Luquez, Federico Perez Manghi, Maria Rosa Ulla, Maria Alejandra Moisello, Virginia Visco, Silvia Gorban De Lapertoza, Silvana Ernestina Solis, Javier Farias, Georgina Sposetti, Pieter Gillard, Pascale Abrams, Marina van Ypersele de Strihou, James Conway, Sue Pedersen, Peter Senior, Joanne F. Liutkus, Churn-Ern Yip, Zubin Punthakee, Frederic Bernier, Heather Lochnan, Vincent Woo, Thomas Elliott, Juan Palma, Carmen Solis Merino, Alfredo Danin Vargas, Ulrich Wendisch, Andreas Reichel, Jochen Seufert, Bernd Becker, Hasan Alawi, Andreas L. Birkenfeld, Christoph Hasslacher, Joerg Luedemann, Thomas Schaum, Cornelia Marck, Joachim Sauter, Ulrich Aigner, Yukiko Onishi, Hiroaki Seino, Yuichi Sato, Kiyohide Nunoi, Akira Yamauchi, Eitaro Nakashima, Hiroki Ikeda, Toshihiko Shiraiwa, Yoshimitsu Yamasaki, Hiroki Yokoyama, Kunihiko Nakamura, Masayuki Noritake, Shozo Miyauchi, Tomomi Hakoda, Yoshihide Hirohata, Atsushi Hasegawa, Yoshihide Fukumoto, Hirotaka Nagashima, Masahiro Takihata, Tetsuro Kamada, Hideaki Jinnouchi, Yuri Ono, Takayuki Watanabe, Hiroshi Ohashi, Masahiko Takai, Tadashi Seguchi, Katsuya Yamazaki, Hajime Maeda, Shingo Iwasaki, H.W. De Valk, Adriaan Kooy, Sabine Landewe-Cleuren, Katarzyna Madziarska, Andrzej Stankiewicz, Katarzyna Wasilewska, Gottfried Rudofsky, Maciej Malecki, Ewa Pankowska, Ewa Szyprowska, Monika Lukaszewicz, Lidia Tokarska, Irina Bondar, Irina Karpova, Ludmila Ruyatkina, Alsu Zalevskaya, Ruslan Sardinov, Yury Khalimov, Folke Sjoberg, Pekka Koskinen, Dan Curiac, Marcus Lind, Birgit Bach-Kliegel, Bernd Schultes, Basil G. Issa, Anne Kilvert, Olivia Pereira, Stephen Bain, Biswa Mishra, Deepak Bhatnagar, Leonard Chuck, David Gorson, David Robertson, Luis Casaubon, Louis Chaykin, Juan Pablo Frias, Stanley Hsia, Robert Jenders, Sam Lerman, Scott Segel, Peter Weissman, Anna Chang, John Reed, Ivy-Joan Madu, Peter Bressler, Lisa Abbott, Sumana Gangi, Kate Wheeler, Kenneth Cohen, William Biggs, Serge Jabbour, Dennis Karounos, Sajeev Menon, Wendell Miers, Grazia Aleppo, Gigi Lefebvre, Danny Sugimoto, Robert Ferraro, Richard Kelly, Marcel Twahirwa, Christopher Case, David Klonoff, Paul Denker, Priscilla Hollander, Michelle Welch, Matthew Leinung, Larry Kotek, Janet McGill, Yshay Shlesinger, Cynthia Huffman, Stephen Aronoff, Daniel Lorber, Antonio Terrelonge, Firas Akhrass, Cindy Bredefeld, Kenneth Hershon, James Lenhard, Daniel Donovan, Larry Stonesifer, Craig Greenberg, Eli Ipp, Anuj Bhargava & Shichun Bao. (2018) Efficacy and Safety of Dapagliflozin in Patients With Inadequately Controlled Type 1 Diabetes (the DEPICT-2 Study): 24-Week Results From a Randomized Controlled Trial. Diabetes Care 41:9, pages 1938-1946.
Crossref
Crossref
Wen Wan, M. Reza Skandari, Alexa Minc, Aviva G. Nathan, Aaron Winn, Parmida Zarei, Michael O’Grady & Elbert S. Huang. (2018) Cost-effectiveness of Continuous Glucose Monitoring for Adults With Type 1 Diabetes Compared With Self-Monitoring of Blood Glucose: The DIAMOND Randomized Trial. Diabetes Care 41:6, pages 1227-1234.
Crossref
Crossref
W.H. Polonsky, L. Fisher & D. Hessler. (2018) The impact of non-severe hypoglycemia on quality of life in patients with type 2 diabetes. Journal of Diabetes and its Complications 32:4, pages 373-378.
Crossref
Crossref
Pratik Choudhary & Stephanie A. Amiel. (2018) Hypoglycaemia in type 1 diabetes: technological treatments, their limitations and the place of psychology. Diabetologia 61:4, pages 761-769.
Crossref
Crossref
Manjiri Pawaskar, Edward A. Witt, Samuel S. Engel, Swapnil N. Rajpathak & Kristy Iglay. (2018) Severity of hypoglycaemia and health-related quality of life, work productivity and healthcare costs in patients with type 2 diabetes in Europe. Endocrinology, Diabetes & Metabolism 1:2, pages e00011.
Crossref
Crossref
Ronnie Aronson, Ronald Goldenberg, Damir Boras, Rasmus Skovgaard & Harpreet Bajaj. (2018) The Canadian Hypoglycemia Assessment Tool Program: Insights Into Rates and Implications of Hypoglycemia From an Observational Study. Canadian Journal of Diabetes 42:1, pages 11-17.
Crossref
Crossref
Ahmed IqbalPeter NovodvorskySimon R. Heller. (2018) Recent Updates on Type 1 Diabetes Mellitus Management for Clinicians. Diabetes & Metabolism Journal 42:1, pages 3.
Crossref
Crossref
Luciana Bahia, Rosane Kupfer, Denise Momesso, Debora A. P. Cabral, Balduino Tschiedel, Marcia Pu?ales, Suzana Lavigne, Cristina F. S. Fa?anha, Adriana C. Forti, Angela D. N. Mendes & Bernardo R. Tura. (2017) Health-related quality of life and utility values associated to hypoglycemia in patients with type 1 diabetes mellitus treated in the Brazilian Public Health System: a multicenter study. Diabetology & Metabolic Syndrome 9:1.
Crossref
Crossref
Rifat Emral, Faruque Pathan, Carlos Augusto Yepes Cortés, M. Hesham El-Hefnawy, Su-Yen Goh, Ana Maria Gómez, Angela Murphy, Salah Abusnana, Achmad Rudijanto, Anand Jain, Zhulin Ma & Roberto Mirasol. (2017) Self-reported hypoglycemia in insulin-treated patients with diabetes: Results from an international survey on 7289 patients from nine countries. Diabetes Research and Clinical Practice 134, pages 17-28.
Crossref
Crossref
Anthony P. Nunes, Kristy Iglay, Larry Radican, Samuel S. Engel, Jing Yang, Michael C. Doherty & David D. Dore. (2017) Hypoglycaemia seriousness and weight gain as determinants of cardiovascular disease outcomes among sulfonylurea users. Diabetes, Obesity and Metabolism 19:10, pages 1425-1435.
Crossref
Crossref
Sverre Christian Christiansen, Anders Lyngvi Fougner, Øyvind Stavdahl, Konstanze Kölle, Reinold Ellingsen & Sven Magnus Carlsen. (2017) A Review of the Current Challenges Associated with the Development of an Artificial Pancreas by a Double Subcutaneous Approach. Diabetes Therapy 8:3, pages 489-506.
Crossref
Crossref
Stephanie N. DuBoseRuth S. WeinstockRoy W. BeckAnne L. PetersGrazia AleppoRichard M. BergenstalHenry RodriguezJoseph F. LargayElaine M. MassaroIrl B. Hirsch. (2016) Hypoglycemia in Older Adults with Type 1 Diabetes. Diabetes Technology & Therapeutics 18:12, pages 765-771.
Crossref
Crossref
Nabil El Naggar & Sanjay Kalra. (2016) Switching from Biphasic Human Insulin to Premix Insulin Analogs: A Review of the Evidence Regarding Quality of Life and Adherence to Medication in Type 2 Diabetes Mellitus. Advances in Therapy 33:12, pages 2091-2109.
Crossref
Crossref
Anthony P. Nunes, Jing Yang, Larry Radican, Samuel S. Engel, Karen Kurtyka, Kaan Tunceli, Shengsheng Yu, Kristy Iglay, Michael C. Doherty & David D. Dore. (2016) Assessing occurrence of hypoglycemia and its severity from electronic health records of patients with type 2 diabetes mellitus. Diabetes Research and Clinical Practice 121, pages 192-203.
Crossref
Crossref
Josep Franch Nadal, Manel Mata Cases & Dídac Mauricio Puente. (2016) Epidemiología y control clínico de la diabetes mellitus tipo 2 y sus comorbilidades en España (estudio e-Control). Medicina Clínica 147, pages 1-7.
Crossref
Crossref
Rokhsareh Aghili, William H. Polonsky, Ameneh Ebrahim Valojerdi, Mojtaba Malek, Abbas Ali Keshtkar, Alireza Esteghamati, Mark Heyman & Mohammad Ebrahim Khamseh. (2016) Type 2 Diabetes: Model of Factors Associated with Glycemic Control. Canadian Journal of Diabetes 40:5, pages 424-430.
Crossref
Crossref
Nadine Kuniss, Guido Kramer, Nicolle Müller, Christof Kloos, Gunter Wolf & Ulrich Alfons Müller. (2016) History of mild hypoglycaemia does not affect the prevalence of diabetes-related distress in people with diabetes. Acta Diabetologica 53:5, pages 833-838.
Crossref
Crossref
B. M. Frier, M. M. Jensen & B. D. Chubb. (2015)
Hypoglycaemia in adults with insulin‐treated diabetes in the
UK
: self‐reported frequency and effects
. Diabetic Medicine 33:8, pages 1125-1132.
Crossref
Crossref
Ahmed Iqbal & Simon Heller. (2016) Managing hypoglycaemia. Best Practice & Research Clinical Endocrinology & Metabolism 30:3, pages 413-430.
Crossref
Crossref
Lisa Elliott, Carrie Fidler, Andrea Ditchfield & Trine Stissing. (2016) Hypoglycemia Event Rates: A Comparison Between Real-World Data and Randomized Controlled Trial Populations in Insulin-Treated Diabetes. Diabetes Therapy 7:1, pages 45-60.
Crossref
Crossref
Beatriz D Schaan & Rafael Selbach Scheffel. (2015) Modern insulins, old paradigms and pragmatism: choosing wisely when deciding how to treat type 1 diabetes. Diabetology & Metabolic Syndrome 7:1.
Crossref
Crossref
Meryl Brod, Lise Højbjerre, Donald M. Bushnell & Charlotte Thim Hansen. (2015) Assessing the impact of non-severe hypoglycemic events and treatment in adults: development of the Treatment-Related Impact Measure—Non-severe Hypoglycemic Events (TRIM-HYPO). Quality of Life Research 24:12, pages 2971-2984.
Crossref
Crossref
Marina Vladimirovna Shestakova, Michail Vladimirovich Antciferov, Alexander Yur'evich Mayorov, Luydmila Alexandrovna Ruyatkina, Ludmila Alexandrovna Suplotova, Sergey Anatol'evich Dogadin, Nikolay Borisovich Lebedev & Yana Gennadievna Alekseeva. (2015) Insulin degludec: a new basal insulin analogue with an ultra-long duration of action. Safety and efficacy in Russian patients with diabetes. Diabetes mellitus 18:4, pages 130-141.
Crossref
Crossref
N. Abrahamsson, B. Eden Engstrom, M. Sundbom & F. A. Karlsson. (2015) Hypoglycemia in everyday life after gastric bypass and duodenal switch. European Journal of Endocrinology 173:1, pages 91-100.
Crossref
Crossref
Kenneth Calvin Wiley, Ranti Akiyode & Gail Nunlee-Bland. (2015) Case Study: Use of GLP-1 Receptor Agonist in a Patient on Intensive Insulin Therapy. Diabetes Spectrum 28:2, pages 121-126.
Crossref
Crossref
Nandu Thalange, Larry Deeb, Violeta Iotova, Tomoyuki Kawamura, Georgeanna Klingensmith, Areti Philotheou, Janet Silverstein, Stefano Tumini, Ann‐Marie Ocampo Francisco, Ona Kinduryte & Thomas Danne. (2015) Insulin degludec in combination with bolus insulin aspart is safe and effective in children and adolescents with type 1 diabetes. Pediatric Diabetes 16:3, pages 164-176.
Crossref
Crossref
Stephanie A. Amiel. 2015. International Textbook of Diabetes Mellitus. International Textbook of Diabetes Mellitus
783
798
.
Marie Markert Jensen & Ulrik Pedersen-Bjergaard. (2015) Self-reported frequency and impact of non-severe hypoglycemic events in insulin-treated diabetic patients in Denmark. Diabetes Management 5:2, pages 67-78.
Crossref
Crossref
P. Vellanki & G.E. Umpierrez. (2015) Iatrogenic hypoglycemia and quality of life in patients with type 2 diabetes mellitus. Revista Clínica Española 215:2, pages 104-106.
Crossref
Crossref
Raimund Weitgasser & Sandra Lopes. (2014) Self-reported frequency and impact of hypoglycaemic events in insulin-treated diabetic patients in AustriaHäufigkeit und Auswirkung von Hypoglykämien bei insulinbehandelten Diabetes-Patienten in Österreich. Wiener klinische Wochenschrift 127:1-2, pages 36-44.
Crossref
Crossref
Wenying Yang, Xiaoming Zhuang, Yukun Li, Qing Wang, Rongwen Bian, Jianguo Shen, Eva Hammerby & Li Yang. (2014) Improvements in quality of life associated with biphasic insulin aspart 30 in type 2 diabetes patients in China: results from the A1chieve® observational study. Health and Quality of Life Outcomes 12:1.
Crossref
Crossref
Delia Hendrie, Ted R. Miller, Richard J. Woodman, Kreshnik Hoti & Jeff Hughes. (2014) Cost-Effectiveness of Reducing Glycaemic Episodes Through Community Pharmacy Management of Patients with Type 2 Diabetes Mellitus. The Journal of Primary Prevention 35:6, pages 439-449.
Crossref
Crossref
Bernard Peene & Katrien Benhalima. (2014) Sodium glucose transporter protein 2 inhibitors: focusing on the kidney to treat type 2 diabetes. Therapeutic Advances in Endocrinology and Metabolism 5:5, pages 124-136.
Crossref
Crossref
M. J. Davies, J. L. Gross, Y. Ono, T. Sasaki, G. Bantwal, M. A. Gall, M. Niemeyer & H. Seino. (2014) Efficacy and safety of insulin degludec given as part of basal–bolus treatment with mealtime insulin aspart in type 1 diabetes: a 26‐week randomized, open‐label, treat‐to‐target non‐inferiority trial. Diabetes, Obesity and Metabolism 16:10, pages 922-930.
Crossref
Crossref
Javier Morales & Doron Schneider. (2014) Hypoglycemia. The American Journal of Medicine 127:10, pages S17-S24.
Crossref
Crossref
H.-C. Yu, W.-C. Tsai & P.-T. Kung. (2013) Does the pay-for-performance programme reduce the emergency department visits for hypoglycaemia in type 2 diabetic patients?. Health Policy and Planning 29:6, pages 732-741.
Crossref
Crossref
N. Munro & A. H. Barnett. (2014) Incidence, worry and discussion about dosing irregularities and self-treated hypoglycaemia amongst HCPs and patients with type 2 diabetes: results from the UK cohort of the Global Attitudes of Patient and Physicians (GAPP2) survey. International Journal of Clinical Practice 68:6, pages 692-699.
Crossref
Crossref
Domingo Orozco-Beltrán, Pedro Mezquita-Raya, Antonio Ramírez de Arellano & Manuel Galán. (2014) Self-Reported Frequency and Impact of Hypoglycemic Events in Spain. Diabetes Therapy 5:1, pages 155-168.
Crossref
Crossref
Evgenia Mikhailovna Patrakeeva, Mariia Nikolayevna Dunicheva & Alsu Gafurovna Zalevskaya. (2014) Fear of hypoglycaemia in patients with type 1 diabetes. Diabetes mellitus 17:2, pages 66-75.
Crossref
Crossref
Oliver Schnell & Michael Erbach. (2014) Impact of a Reduced Error Range of SMBG in Insulin-treated Patients in Germany. Journal of Diabetes Science and Technology 8:3, pages 479-482.
Crossref
Crossref
Steven V. EdelmanJamie S. Blose. (2014) The Impact of Nocturnal Hypoglycemia on Clinical and Cost-Related Issues in Patients With Type 1 and Type 2 Diabetes. The Diabetes Educator 40:3, pages 269-279.
Crossref
Crossref
Duong Thuy Tran, Louisa R. Jorm, Maree Johnson, Hilary J. Bambrick & Sanja Lujic. (2014) Type 2 diabetes hospitalisation and mortality in Vietnamese immigrants in Australia. Diabetes Research and Clinical Practice 104:1, pages e12-e15.
Crossref
Crossref
Silvia Paz, Diego González Segura, Anna Raya Torres & Luis Lizan. (2014) Principales factores asociados al coste de la diabetes mellitus tipo 2: revisión de la literatura. Avances en Diabetología 30:2, pages 34-44.
Crossref
Crossref
Stewart Harris, Muhammad Mamdani, Claus B. Galbo-Jørgensen, Mette Bøgelund, Jens Gundgaard & Danielle Groleau. (2014) The Effect of Hypoglycemia on Health-Related Quality of Life: Canadian Results from a Multinational Time Trade-off Survey. Canadian Journal of Diabetes 38:1, pages 45-52.
Crossref
Crossref
C. G. Östenson, P. Geelhoed‐Duijvestijn, J. Lahtela, R. Weitgasser, M. Markert Jensen & U. Pedersen‐Bjergaard. (2013) Self‐reported non‐severe hypoglycaemic events in Europe. Diabetic Medicine 31:1, pages 92-101.
Crossref
Crossref
Francisco Javier Ampudia-Blasco. (2014) Aspectos clínicamente relevantes para pacientes diabéticos en tratamiento con insulina: prevención de hipoglucemias y flexibilidad en la administración. Avances en Diabetología 30:1, pages 1-8.
Crossref
Crossref
Pratik ChoudharySharmin RamasamyLouisa GreenGeraldine GallenSiobhan PenderAnna BrackenridgeStephanie A. AmielJohn C. Pickup. (2013) Real-Time Continuous Glucose Monitoring Significantly Reduces Severe Hypoglycemia in Hypoglycemia-Unaware Patients With Type 1 Diabetes. Diabetes Care 36:12, pages 4160-4162.
Crossref
Crossref
Richa Redhu Gehlaut & Jay Shubrook. (2013) Revisiting hypoglycemia in diabetes. Osteopathic Family Physician.
Crossref
Crossref
Véronique Kerlan, Didier Gouet, Michel Marre & Éric Renard. (2013) Use of insulin degludec, a new basal insulin with an ultra-long duration of action, in basal–bolus therapy in type 1 and type 2 diabetes. Annales d'Endocrinologie 74:5-6, pages 487-490.
Crossref
Crossref
L. Lindner, R. Garc?a-S?nchez, C. Alvarez, L. Beteg?n & X. Badia. (2013) Hospitalizations due to severe hypoglycemia in patients with diabetes mellitus in Spain. Revista Cl?nica Espa?ola (English Edition) 213:8, pages 370-376.
Crossref
Crossref
L. Lindner, R. Garc?a-S?nchez, C. Alvarez, L. Beteg?n & X. Badia. (2013) Hospitalizaciones por hipoglucemia grave en pacientes con diabetes mellitus en Espa?a. Revista Cl?nica Espa?ola 213:8, pages 370-376.
Crossref
Crossref
M. Te?fila Vicente-Herrero, M. Jes?s Terradillos Garc?a, Luisa M. Capdevila Garc?a, M. Victoria Ram?rez I?iguez de la Torre & ?ngel Arturo L?pez-Gonz?lez. (2013) Costes por incapacidad temporal en Espa?a derivados de la diabetes mellitus y sus complicaciones. Endocrinolog?a y Nutrici?n 60:8, pages 447-455.
Crossref
Crossref
M. Te?fila Vicente-Herrero, M. Jes?s Terradillos Garc?a, Luisa M. Capdevila Garc?a, M. Victoria Ram?rez I?iguez de la Torre & ?ngel Arturo L?pez-Gonz?lez. (2013) Costs of temporary disability in Spain related to diabetes mellitus and its complications. Endocrinolog?a y Nutrici?n (English Edition) 60:8, pages 447-455.
Crossref
Crossref
Rozalina. G. McCoy, Holly. K. Van Houten, Jeanette. Y. Ziegenfuss, Nilay. D. Shah, Robert. A. Wermers & Steven. A. Smith. (2013) Self-Report of Hypoglycemia and Health-Related Quality of Life in Patients with Type 1 and Type 2 Diabetes. Endocrine Practice 19:5, pages 792-799.
Crossref
Crossref
N. Freemantle, M. Evans, T. Christensen, M. L. Wolden & J. B. Bjorner. (2013) A comparison of health‐related quality of life (health utility) between insulin degludec and insulin glargine: a meta‐analysis of phase 3 trials. Diabetes, Obesity and Metabolism 15:6, pages 564-571.
Crossref
Crossref
M. Brod, M. Wolden, T. Christensen & D. M. Bushnell. (2013) A nine country study of the burden of non‐severe nocturnal hypoglycaemic events on diabetes management and daily function. Diabetes, Obesity and Metabolism 15:6, pages 546-557.
Crossref
Crossref
Jocelyne Moisan, Marie-Claude Breton, Julie Villeneuve & Jean-Pierre Gr?goire. (2013) Hypoglycemia-Related Emergency Department Visits and Hypoglycemia-Related Hospitalizations among New Users of Antidiabetes Treatments. Canadian Journal of Diabetes 37:3, pages 143-149.
Crossref
Crossref
Meryl Brod, Betsy Pohlman, Michael Wolden & Torsten Christensen. (2012) Non-severe nocturnal hypoglycemic events: experience and impacts on patient functioning and well-being. Quality of Life Research 22:5, pages 997-1004.
Crossref
Crossref
Elizabeth R. SeaquistJohn AndersonBelinda Childs, Philip Cryer, Samuel Dagogo-JackLisa Fish, Simon R. Heller, Henry RodriguezJames Rosenzweig & Robert Vigersky. (2013) Hypoglycemia and Diabetes: A Report of a Workgroup of the American Diabetes Association and The Endocrine Society. Diabetes Care 36:5, pages 1384-1395.
Crossref
Crossref
Elizabeth R. Seaquist, John Anderson, Belinda Childs, Philip Cryer, Samuel Dagogo-Jack, Lisa Fish, Simon R. HellerHenry Rodriguez, James Rosenzweig & Robert Vigersky. (2013) Hypoglycemia and Diabetes: A Report of a Workgroup of the American Diabetes Association and The Endocrine Society. The Journal of Clinical Endocrinology & Metabolism 98:5, pages 1845-1859.
Crossref
Crossref
Jennifer D Goldman-Levine, Dhiren K Patel & David M Schnee. (2013) Insulin Degludec: A Novel Basal Insulin Analogue. Annals of Pharmacotherapy 47:2, pages 269-277.
Crossref
Crossref
Marc Evans, Kamlesh Khunti, Muhammad Mamdani, Claus B Galbo-Jørgensen, Jens Gundgaard, Mette Bøgelund & Stewart Harris. (2013) Health-related quality of life associated with daytime and nocturnal hypoglycaemic events: a time trade-off survey in five countries. Health and Quality of Life Outcomes 11:1, pages 90.
Crossref
Crossref
Stuart Little, Thomas Chadwick, Pratik Choudhary, Cath Brennand, Julia Stickland, Shalleen Barendse, Tolulope Olateju, Lalantha Leelarathna, Emma Walkinshaw, Horng K Tan, Sally M Marshall, Reena M Thomas, Simon Heller, Mark Evans, David Kerr, Daniel Flanagan, Jane Speight & James AM Shaw. (2012) Comparison of Optimised MDI versus Pumps with or without Sensors in Severe Hypoglycaemia (the Hypo COMPaSS trial). BMC Endocrine Disorders 12:1.
Crossref
Crossref
Hélène Gilet, Jean-Bernard Gruenberger, Giovanni Bader & Muriel Viala-Danten. (2012) Demonstrating the Burden of Hypoglycemia on Patients' Quality of Life in Diabetes Clinical Trials: Measurement Considerations for Hypoglycemia. Value in Health 15:8, pages 1036-1041.
Crossref
Crossref
A. Penfornis, I. Bourdel-Marchasson, S. Quere & S. Dejager. (2012) Real-life comparison of DPP4-inhibitors with conventional oral antidiabetics as add-on therapy to metformin in elderly patients with type 2 diabetes: The HYPOCRAS study. Diabetes & Metabolism 38:6, pages 550-557.
Crossref
Crossref
Gita Shafiee, Mohammadreza Mohajeri-Tehrani, Mohammad Pajouhi & Bagher Larijani. (2012) The importance of hypoglycemia in diabetic patients. Journal of Diabetes & Metabolic Disorders 11:1.
Crossref
Crossref
Setareh A. Williams, Lizheng Shi, Susan K. Brenneman, Jonathan C. Johnson, Jessica C. Wegner & Vivian Fonseca. (2012) The burden of hypoglycemia on healthcare utilization, costs, and quality of life among type 2 diabetes mellitus patients. Journal of Diabetes and its Complications 26:5, pages 399-406.
Crossref
Crossref
Pamela Shu-Xian Tan, Hui-Chen Chen, Beverley Joan Taylor & Desley Gail Hegney. (2012) Exploring the meaning of hypoglycaemia to community-dwelling Singaporean Chinese adults living with type 2 diabetes mellitus. International Journal of Nursing Practice 18:3, pages 252-259.
Crossref
Crossref
Wayne H.-H. Sheu, Li-Nong Ji, Wannee Nitiyanant, Sei Hyun Baik, Donald Yin, Panagiotis Mavros & Siew-Pheng Chan. (2012) Hypoglycemia is associated with increased worry and lower quality of life among patients with type 2 diabetes treated with oral antihyperglycemic agents in the Asia-Pacific region. Diabetes Research and Clinical Practice 96:2, pages 141-148.
Crossref
Crossref
A. H. Barnett. (2011) The role of GLP‐1 mimetics and basal insulin analogues in type 2 diabetes mellitus: guidance from studies of liraglutide. Diabetes, Obesity and Metabolism 14:4, pages 304-314.
Crossref
Crossref
Simon Heller, John Buse, Miles Fisher, Satish Garg, Michel Marre, Ludwig Merker, Eric Renard, David Russell-Jones, Areti Philotheou, Ann Marie Ocampo Francisco, Huiling Pei & Bruce Bode. (2012) Insulin degludec, an ultra-longacting basal insulin, versus insulin glargine in basal-bolus treatment with mealtime insulin aspart in type 1 diabetes (BEGIN Basal-Bolus Type 1): a phase 3, randomised, open-label, treat-to-target non-inferiority trial. The Lancet 379:9825, pages 1489-1497.
Crossref
Crossref
W. J. Valentine, J. Jendle, M. Saraheimo, B. Thorsteinsson, R. F. Pollock & M. Lammert. (2012) Evaluating the cost‐effectiveness of reduced mild hypoglycaemia in subjects with Type 1 diabetes treated with insulin detemir or NPH insulin in Denmark, Sweden, Finland and the Netherlands. Diabetic Medicine 29:3, pages 303-312.
Crossref
Crossref
S. Barendse, H. Singh, B. M. Frier & J. Speight. (2012) The impact of hypoglycaemia on quality of life and related patient‐reported outcomes in Type 2 diabetes: a narrative review. Diabetic Medicine 29:3, pages 293-302.
Crossref
Crossref
Niyukta Thakare, Rono Mukherjee, Andrew M. Sinclair, Sherif Elsobky & Ian Pearce. (2012) The Assessment and Peri-Operative Management of Diabetes Mellitus in Urological Day Case Surgery—Outcomes of the North West of England Regional Audit. British Journal of Medical and Surgical Urology 5:2, pages 78-83.
Crossref
Crossref
Elizabeth Marrett, Larry Radican, Michael J Davies & Qiaoyi Zhang. (2011) Assessment of severity and frequency of self-reported hypoglycemia on quality of life in patients with type 2 diabetes treated with oral antihyperglycemic agents: A survey study. BMC Research Notes 4:1.
Crossref
Crossref
U. L. Malanda, S. D. Bot, D. P. French, P. J. Kostense, A. N. Wade, J. M. Dekker, G. Nijpels & A. J. Farmer. (2011) Experience of hypoglycaemia is associated with changes in beliefs about diabetes in patients with Type 2 diabetes. Diabetic Medicine 28:11, pages 1395-1400.
Crossref
Crossref
Riccardo Perfetti. (2011) Combining Basal Insulin Analogs with Glucagon-Like Peptide-1 Mimetics. Diabetes Technology & Therapeutics 13:9, pages 873-881.
Crossref
Crossref
Ana Vieta, Xavier Badia & José A. Sacristán. (2011) A Systematic Review of Patient-Reported and Economic Outcomes: Value to Stakeholders in the Decision-Making Process in Patients With Type 2 Diabetes Mellitus. Clinical Therapeutics 33:9, pages 1225-1245.
Crossref
Crossref
Clare MacArthur. (2011) Unit 4. Article 1 Hypoglycaemia in type 2 diabetes. Practice Nursing 22:8, pages 1-4.
Crossref
Crossref
Meryl Brod, Torsten Christensen, Trine L. Thomsen & Donald M. Bushnell. (2011) The Impact of Non-Severe Hypoglycemic Events on Work Productivity and Diabetes Management. Value in Health 14:5, pages 665-671.
Crossref
Crossref
W. E. Schmidt, J. S. Christiansen, M. Hammer, M. J. Zychma & J. B. Buse. (2011) Patient-reported outcomes are superior in patients with Type?2 diabetes treated with liraglutide as compared with exenatide, when added to metformin, sulphonylurea or both: results from a randomized, open-label study. Diabetic Medicine 28:6, pages 715-723.
Crossref
Crossref
O. O. Ogundipe, J. Geddes, A. M. Leckie & B. M. Frier. (2011) Impaired hypoglycaemia awareness and employment in people with Type 1 diabetes. Occupational Medicine 61:4, pages 241-246.
Crossref
Crossref
Sylvie Dejager & Anja Schweizer. (2011) Minimizing the risk of hypoglycemia with vildagliptin: Clinical experience, mechanistic basis, and importance in type 2 diabetes management. Diabetes Therapy 2:2, pages 51-66.
Crossref
Crossref
Kåre I. Birkeland, Philip D. HomeUlrich Wendisch, Robert E. Ratner, Thue Johansen, Lars A. Endahl, Karsten Lyby, Johan H. Jendle, Anthony P. Roberts, J. Hans DeVries & Luigi F. Meneghini. (2011) Insulin Degludec in Type 1 Diabetes. Diabetes Care 34:3, pages 661-665.
Crossref
Crossref
Setareh A. Williams, Michael F. Pollack & Marco DiBonaventura. (2011) Effects of hypoglycemia on health-related quality of life, treatment satisfaction and healthcare resource utilization in patients with type 2 diabetes mellitus. Diabetes Research and Clinical Practice 91:3, pages 363-370.
Crossref
Crossref
Fernando Alvarez-Guisasola, Donald D Yin, Gonzalo Nocea, Ying Qiu & Panagiotis Mavros. (2010) Association of hypoglycemic symptoms with patients' rating of their health-related quality of life state: a cross sectional study. Health and Quality of Life Outcomes 8:1.
Crossref
Crossref
P. D. Home, A. Fritsche, S. Schinzel & M. Massi‐Benedetti. (2010) Meta‐analysis of individual patient data to assess the risk of hypoglycaemia in people with type 2 diabetes using NPH insulin or insulin glargine. Diabetes, Obesity and Metabolism 12:9, pages 772-779.
Crossref
Crossref
B. W. Bode, M. A. Testa, M. Magwire, P. M. Hale, M. Hammer, L. Blonde & A. Garber. (2010) Patient-reported outcomes following treatment with the human GLP-1 analogue liraglutide or glimepiride in monotherapy: results from a randomized controlled trial in patients with type 2 diabetes. Diabetes, Obesity and Metabolism 12:7, pages 604-612.
Crossref
Crossref
Kjeld Hermansen, Ronette L. Kolotkin, Mette Hammer, Milan Zdravkovic & David Matthews. (2010) Patient-reported outcomes in patients with type 2 diabetes treated with liraglutide or glimepiride, both as add-on to metformin. Primary Care Diabetes 4:2, pages 113-117.
Crossref
Crossref
H David McIntyreBrigid A KnightDianne M HarveyMarina N NoudVirginia L HaggerKristen S Gilshenan. (2010) Dose adjustment for normal eating (DAFNE) — an audit of outcomes in Australia. Medical Journal of Australia 192:11, pages 637-640.
Crossref
Crossref
Clare MacArthur. (2010) Hypoglycaemia in type 2 diabetes. Practice Nursing 21:4, pages 206-209.
Crossref
Crossref
Clifford J BaileyCaroline Day. (2010) Hypoglycaemia: a limiting factor. The British Journal of Diabetes & Vascular Disease 10:1, pages 2-4.
Crossref
Crossref
Monika Talarowska, Antoni Florkowski, Krzysztof Zboralski & Piotr Gałecki. (2009) Cognitive functions and clinical features among diabetic patients in Polish population. Open Medicine 4:4, pages 467-475.
Crossref
Crossref
C. Falconnier Bendik, U. Keller, N. Moriconi, A. Gessler, Ch. Schindler, H. Zulewski, J. Ruiz & J.J. Puder. (2009) Training in flexible intensive insulin therapy improves quality of life, decreases the risk of hypoglycaemia and ameliorates poor metabolic control in patients with type 1 diabetes. Diabetes Research and Clinical Practice 83:3, pages 327-333.
Crossref
Crossref
György Jermendy, Diana Erdesz, Laszlo Nagy, Don Yin, Hemant Phatak, Sudeep Karve, Samuel Engel & Rajesh Balkrishnan. (2008) Outcomes of adding second hypoglycemic drug after metformin monotherapy failure among type 2 diabetes in Hungary. Health and Quality of Life Outcomes 6:1.
Crossref
Crossref
P. Vexiau, P. Mavros, G. Krishnarajah, R. Lyu & D. Yin. (2008) Hypoglycaemia in patients with type 2 diabetes treated with a combination of metformin and sulphonylurea therapy in France. Diabetes, Obesity and Metabolism 10:s1, pages 16-24.
Crossref
Crossref
F. ?lvarez Guisasola, S. Tof? Povedano, G. Krishnarajah, R. Lyu, P. Mavros & D. Yin. (2008) Hypoglycaemic symptoms, treatment satisfaction, adherence and their associations with glycaemic goal in patients with type 2 diabetes mellitus: findings from the Real-Life Effectiveness and Care Patterns of Diabetes Management (RECAP-DM) Study. Diabetes, Obesity and Metabolism 10:s1, pages 25-32.
Crossref
Crossref
Patrick J. Boyle & John Zrebiec. (2008) Impact of therapeutic advances on hypoglycaemia in type 2 diabetes. Diabetes/Metabolism Research and Reviews 24:4, pages 257-285.
Crossref
Crossref
S. A. Amiel, T. Dixon, R. Mann & K. Jameson. (2008) Hypoglycaemia in Type 2 diabetes. Diabetic Medicine 25:3, pages 245-254.
Crossref
Crossref
A. Nicolucci, A. Maione, M. Franciosi, R. Amoretti, E. Busetto, F. Capani, D. Bruttomesso, P. Di Bartolo, A. Girelli, F. Leonetti, L. Morviducci, P. Ponzi & E. Vitacolonna. (2008) Quality of life and treatment satisfaction in adults with Type 1 diabetes: a comparison between continuous subcutaneous insulin infusion and multiple daily injections. Diabetic Medicine 25:2, pages 213-220.
Crossref
Crossref
Martha M. Funnell. (2008) Quality of Life and Insulin Therapy in Type 2 Diabetes Mellitus. Insulin 3:1, pages 31-36.
Crossref
Crossref
C. J. Currie. (2007) Reliably assessing the cost-effectiveness of continuous subcutaneous insulin infusion vs. multiple daily injections in the UK: what are the issues?. Diabetic Medicine 24:10, pages 1058-1059.
Crossref
Crossref
L. M. Delahanty, R. W. Grant, E. Wittenberg, J. L. Bosch, D. J. Wexler, E. Cagliero & J. B. Meigs. (2007) Association of diabetes-related emotional distress with diabetes treatment in primary care patients with Type 2 diabetes. Diabetic Medicine 24:1, pages 48-54.
Crossref
Crossref
C. J. Currie, C. D. Poole, A. Woehl, C. Ll. Morgan, S. Cawley, M. D. Rousculp, M. T. Covington & J. R. Peters. (2006) The health-related utility and health-related quality of life of hospital-treated subjects with type 1 or type 2 diabetes with particular reference to differing severity of peripheral neuropathy. Diabetologia 49:10, pages 2272-2280.
Crossref
Crossref
CRAIG J. CURRIE, PHIL MCEWAN, CHRIS D. POOLE, ISAAC A.O. ODEYEMI, SHIBENDRA N. DATTA & CHRISTOPHER L. MORGAN. (2006) The impact of the overactive bladder on health-related utility and quality of life. BJU International 97:6, pages 1267-1272.
Crossref
Crossref